(Q33364244)

English

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma (English)
Barbara MacGregor-Cortelli
Michael Stubblefield

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit